Farnesol (FAR) has already demonstrated an inhibitory effect on Candida albicans biofilm. The aim of this work was to determine the effectiveness of externally added FAR in combination with fluconazole (FLC) on Candida albicans biofilm and on regulation of the ergosterol genes ERG20, ERG9, and ERG11. The effectiveness of compounds was determined by MTT assay and evaluated by the minimal inhibitory concentrations reducing a sessile biofilm to 50% activity (0.5 μg/mL and 200 μmol/L for FLC and FAR, respectively). These concentrations as well as 30 and 100 μmol/L FAR were selected for a study of the effectiveness of the FAR/FLC combination. The reduction in biofilm robustness mainly caused by the presence of 200 μmol/L FAR-alone or in combination with FLC-was accompanied by a significant inhibition of the yeast-to-hyphae transition that was observed by light microscopy and CLSM. Results from qRT-PCR indicated that while 30 μmol/L FAR only slightly regulated the expression of all 3 genes in the 48-h biofilm, the presence of 200 μmol/L FAR downregulated all the tested genes. However, the addition of 0.5 μg/mL of FLC to the samples with 200 μmol/L FAR restored the downregulation of the ERG20 and ERG11 genes to the control level. Moreover, the gene ERG9 was slightly upregulated. In summary, FAR acted via multiple effects on the C. albicans biofilm, but only a higher concentration of FAR proved to be effective.

Department of Microbiology and Virology Faculty of Natural Sciences Comenius University in Bratislava Ilkovičova 6 842 15 Bratislava Slovakia

Zobrazit více v PubMed

Antimicrob Agents Chemother. 2011 Oct;55(10 ):4834-43 PubMed

J Antimicrob Chemother. 2003 May;51(5):1203-11 PubMed

Photochem Photobiol. 2015 Sep-Oct;91(5):1181-90 PubMed

Biochim Biophys Acta. 2014 Sep;1842(9):1855-69 PubMed

Curr Genet. 2013 Nov;59(4):251-64 PubMed

Appl Environ Microbiol. 2001 Jul;67(7):2982-92 PubMed

Microbes Infect. 2016 May;18(5):310-21 PubMed

J Med Microbiol. 2011 Nov;60(Pt 11):1643-50 PubMed

Biochimie. 2000 Aug;82(8):733-8 PubMed

Methods. 2001 Dec;25(4):402-8 PubMed

FEBS Lett. 1998 Sep 4;434(3):406-8 PubMed

Antimicrob Agents Chemother. 2008 Sep;52(9):3259-66 PubMed

Eukaryot Cell. 2010 Apr;9(4):569-77 PubMed

Clin Microbiol Infect. 2016 Jan;22(1):87-93 PubMed

Antimicrob Agents Chemother. 2008 May;52(5):1859-61 PubMed

Mol Gen Genet. 1984;198(2):179-82 PubMed

Fungal Genet Biol. 2011 Aug;48(8):747-63 PubMed

Antimicrob Agents Chemother. 2012 Feb;56(2):770-5 PubMed

Curr Top Med Mycol. 1985;1:313-51 PubMed

PLoS One. 2011 Apr 07;6(4):e18394 PubMed

Mycoses. 2009 Mar;52(2):118-28 PubMed

Antimicrob Agents Chemother. 2001 Sep;45(9):2475-9 PubMed

J Immunol Methods. 1983 Dec 16;65(1-2):55-63 PubMed

PLoS One. 2011;6(12):e28830 PubMed

Yeast. 1998 Dec;14(16):1471-510 PubMed

Antimicrob Agents Chemother. 2000 Oct;44(10 ):2693-700 PubMed

Antimicrob Agents Chemother. 2009 Jun;53(6):2392-401 PubMed

J Antimicrob Chemother. 2003 Jul;52(1):1 PubMed

Antimicrob Agents Chemother. 1998 Feb;42(2):241-53 PubMed

J Med Vet Mycol. 1988 Feb;26(1):57-65 PubMed

Folia Microbiol (Praha). 2015 Jan;60(1):45-51 PubMed

Appl Environ Microbiol. 2002 Nov;68(11):5459-63 PubMed

FEMS Microbiol Lett. 1993 Sep 15;112(3):329-33 PubMed

Med Mycol. 2012 May;50(4):353-60 PubMed

Lipids. 1989 Dec;24(12 ):1020-3 PubMed

Med Mycol. 2012 May;50(4):337-45 PubMed

Antimicrob Agents Chemother. 2007 Jul;51(7):2454-63 PubMed

J Antimicrob Chemother. 2015 Feb;70(2):470-8 PubMed

Appl Environ Microbiol. 2005 Aug;71(8):4938-40 PubMed

Antimicrob Agents Chemother. 2004 Jun;48(6):2305-7 PubMed

Annu Rev Microbiol. 1995;49:95-116 PubMed

Antimicrob Agents Chemother. 2015 Jan;59(1):450-60 PubMed

Biochem J. 1989 Oct 15;263(2):573-9 PubMed